Brivanib is a dual kinase inhibitor used in the treatment of advanced liver cancer (hepatocellular carcinoma). It works by blocking the activity of VEGFR and FGFR, proteins involved in tumor blood supply and growth. It is typically used when other treatments are not effective.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Brivanib and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Brivanib impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Brivanib-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
